
Loading, please wait...

Loading, please wait...

Essential tremor causes severe functional disability among aging adults worldwide. Consequently, stereotactic neurosurgery provides essential relief for medically refractory cases. Magnetic resonance-guided focused ultrasound (MRgFUS) has gained widespread global popularity since regulatory approval in 2016. The procedure delivers thermal energy to the ventral intermediate nucleus of the thalamus without craniotomy. However, several patients experience tremor recurrence over time due to incomplete lesioning or disease progression. Therefore, clinicians increasingly consider salvage deep brain stimulation (DBS) to restore functional independence. Evaluating the safety of DBS after MRgFUS represents an urgent clinical priority for functional neurosurgeons.
Historically, surgeons hesitated to place electrodes through previously ablated brain tissue. Many practitioners feared poor lead compliance, altered impedances, and elevated hemorrhage risks. In addition, anatomical distortion from previous thermal injury might displace target nuclei. Recent clinical evidence, however, demonstrates that neurosurgeons can safely execute DBS after MRgFUS without catastrophic perioperative complications. Furthermore, stereotactic navigation systems readily accommodate prior ablation cavities. As functional neurosurgery centers expand their ablative programs, rescue stimulation protocols will emerge as standard clinical practice. Thus, understanding this multimodal transition empowers clinicians to optimize patient pathways.
Ablative thalamotomy creates focal coagulative necrosis within the motor thalamus. Specifically, clinicians target tremor-synchronous neurons in the ventral intermediate nucleus. Many patients experience immediate tremor suppression during intraoperative acoustic sonications. However, clinical benefits can diminish during long-term follow-up. Histological and imaging studies reveal that surrounding perilesional edema resolves over subsequent weeks. Therefore, temporary edema often mimics permanent tissue destruction during early evaluations. When the surrounding edema recedes, surviving thalamocortical oscillatory circuits may reactivate tremor pathways.
Furthermore, progressive neurodegenerative processes can worsen tremor amplitude across decades. Patients initially treated unilaterally frequently develop progressive contralateral or axial symptoms. In addition, skull density characteristics sometimes limit the delivery of adequate acoustic energy during initial MRgFUS. Consequently, surgeons may create sub-therapeutic thermal lesions to protect nearby internal capsule tracts. When tremor recurs, repeating focused ultrasound carries cumulative risks of dysarthria and gait ataxia. Hence, deep brain stimulation offers an adjustable alternative that preserves neurological function through programmable neuromodulation.
Implanting electrodes into chronically scarred brain parenchyma presents unique stereotactic challenges. Gliosis surrounding the old lesion cavity can theoretically alter brain tissue resistance. Consequently, neurosurgeons must perform meticulous preoperative trajectory planning using advanced magnetic resonance imaging. High-resolution structural sequences clearly define the residual thalamic border and cystic ablation cavity. Furthermore, modern tractography allows precise visualization of the dentato-rubro-thalamic tract and adjacent corticospinal pathways.
During surgery, neurosurgeons adjust the entry angle to avoid traversing dense central glial scars whenever feasible. Moreover, microelectrode recording provides real-time physiological verification of kinesthetic tremor cells. Clinicians frequently observe typical rhythmic bursting patterns near the lesion periphery. In addition, macrostimulation testing confirms therapeutic tremor control without evoking sensory paresthesias or motor contractions. If previous ablation leaves inadequate tissue on one side, surgeons can consider bilateral lead placement. Careful intraoperative monitoring therefore ensures accurate lead positioning without increasing the incidence of parenchymal hemorrhage.
Recent clinical studies confirm the technical feasibility and safety of rescue neuromodulation. For instance, investigators evaluated three refractory essential tremor patients who underwent DBS after prior MRgFUS. The cohort included individuals between 58 and 85 years of age who developed recurrent disabling tremors. Notably, one patient previously underwent two distinct focused ultrasound procedures before lead implantation. Another patient required bilateral electrode placement to address emergent midline axial tremor.
Importantly, the surgical teams reported zero intraoperative hemorrhages, hardware infections, or 30-day hospital readmissions across all cases. Two out of three patients achieved substantial tremor reduction following pulse generator activation. Meanwhile, one patient experienced minimal improvement, eventually requiring revision surgery with dual electrodes. Although clinical efficacy varied, the absence of structural complications highlights procedure safety. Thus, existing data indicate that prior thalamotomy does not inherently compromise subsequent electrode implantation. Clinicians can confidently pursue stimulation when ablative therapy fails to provide durable symptom suppression.
These clinical findings carry crucial implications for multidisciplinary movement disorder teams. Previously, some physicians viewed focused ultrasound as a terminal therapeutic option that precluded future surgery. However, confirming the safety of rescue DBS fundamentally changes preoperative patient counseling. Patients with severe tremor and moderate surgical risk can confidently choose MRgFUS as a primary incisionless intervention. If tremor recurs years later, advanced neuromodulation remains a viable secondary therapy.
Nevertheless, clinicians must maintain realistic expectations regarding rescue functional outcomes. As observed in published cases, extensive local scarring can occasionally limit tremor suppression from rescue stimulation. Therefore, neurologists should discuss potential variability in therapeutic response during initial consultations. Furthermore, multidisciplinary panels should carefully evaluate patient age, cognitive status, and anatomical feasibility before offering revision surgery. Establishing clear clinical algorithms will standardize patient transitions between thermal ablation and neuromodulatory platforms. Consequently, structured counseling empowers individuals to make informed choices throughout their disease course.
While preliminary case reports offer reassuring safety signals, significant knowledge gaps persist. Specifically, the optimal interval between thermal ablation and electrode implantation remains uncertain. Operating too early might aggravate resolving tissue inflammation, whereas prolonged delays allow progressive functional decline. Therefore, prospective multicenter registries must track larger patient cohorts over extended follow-up intervals. Such studies will systematically define electrical impedance changes and stimulation thresholds within gliotic tissue.
In addition, advanced directional lead technologies may overcome anatomical distortions caused by prior thalamic lesions. Directional steering enables clinicians to steer electrical currents away from sensitive internal capsule fibers while focusing energy on surviving tremor circuits. Moreover, integrating connectomic imaging could identify optimal rescue stimulation targets before entering the operating room. Functional neurosurgeons in India and worldwide are rapidly adopting these combined modalities to treat refractory movement disorders. Ultimately, continued scientific investigation will establish evidence-based guidelines for rescue DBS after MRgFUS.
Clinical evidence demonstrates that deep brain stimulation is safe after focused ultrasound ablation. Neurosurgeons can implant stimulation electrodes near prior ablation cavities without experiencing increased rates of intracranial hemorrhage, infection, or perioperative complications. However, surgeons must use high-resolution neuroimaging to navigate around existing glial scar tissue effectively.
Patients may require deep brain stimulation because tremor symptoms can recur following thermal ablation. As perilesional edema resolves over several weeks, surviving thalamic circuits may reactivate tremor oscillations. Furthermore, some patients develop progressive bilateral symptoms or experience incomplete tremor suppression, prompting clinicians to offer rescue stimulation for improved symptom control.
Most patients experience substantial tremor reduction following rescue stimulation, although clinical efficacy can vary. Dense central scarring from previous ablation may restrict electric field distribution or alter local tissue impedance. Consequently, while many individuals regain functional control, select patients achieve modest relief and may require specialized lead configurations or revisions.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A landmark case series demonstrates that deep brain stimulation (DBS) is safe and feasible following MRI-guided focused ultrasound ablation in refractory essential tremor, providing a viable rescue therapy for tremor recurrence without increasing surgical complication rates.
Today

A prospective machine learning study demonstrates that an interpretable XGBoost model using 30 photoplethysmography features accurately estimates continuous blood pressure in intensive care units, achieving Grade A British Hypertension Society standards and reducing reliance on invasive arterial catheters.
Today

A qualitative study on the Dutch HPV vaccination catch-up campaign reveals that young adult hesitancy stems from information gaps and accessibility barriers rather than rampant misinformation. Clinicians can leverage these social listening insights to improve vaccine communication and address patient concerns.
Today

A multicenter longitudinal study of the CHARLS and HRS cohorts demonstrates that elevated cumulative pulse pressure and high-stable trajectories significantly increase incident sarcopenia risk in older adults, particularly in those with heart disease, linking arterial stiffness directly to progressive muscle loss.
Today

A 491-patient cohort study in Sudan reveals critical insights into war trauma reconstructive surgery, analyzing injury patterns, soft-tissue procedures, and a 25.5% complication rate in resource-limited conflict zones.
Today

A secondary analysis of the Living Healthier with Diabetes trial reveals that positive baseline technology attitudes significantly improve engagement with digital diabetes self-management apps, leading to enhanced self-care behaviors and better long-term glycemic control in adults with type 2 diabetes.
Today